White Paper
Report on Post-approval Stage Projects under the Concept of Patient-centricity in Chinese Pharmaceutical Industry
Oct 10, 2022
Download

Initiated by Pfizer China, IQVIA has carried out survey so as to better understand the status quo of "patient-centric" projects in pharmaceutical industry of China. This report, titled as Report on Post-approval stage Projects under the Concept of Patient-centricity in Chinese Pharmaceutical Industry(2021), presents a general overview of all stakeholders' current thinking on patient-centricity and their practical experience based on in-depth interviews with major players in the pharmaceutical industry (foreign companies and domestic ones), academia/associations, foundations, patient communities and healthcare providers along with IQVIA's previous project experience. Addressing the present situation and/or advices for the post-approval stage industry growing, this report aims to provide a visionary insight for the continuous improvement and practice of patient centricity in Chinese pharmaceutical industry. Key information and conclusions are listed here for quick reference by industry experts and peers.

Contact Us